ClinConnect ClinConnect Logo
Search / Trial NCT05701111

Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress

Launched by STANFORD UNIVERSITY · Jan 24, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Building Resilience at Schools," aims to help teachers and school-aged children in Puerto Rico who are experiencing stress and burnout due to recent natural disasters and the COVID-19 pandemic. The study will explore two types of treatment: a mindfulness program for educators and, for children showing signs of Post Traumatic Stress Disorder (PTSD), this mindfulness training along with a therapy called Cue-Centered Therapy (CCT). The goal is to see how these treatments can improve the mental well-being of educators and support children in developing better emotional skills during tough times.

To participate in the trial, teachers and students at selected schools can sign up, especially if children aged 11-17 have faced traumatic events and show PTSD symptoms. Participants can expect to take part in these mindfulness and therapy sessions, which aim to provide them with tools to manage stress and improve overall mental health. The researchers also hope to learn about the biological factors that may help some individuals be more resilient in the face of adversity, which will guide future mental health support in schools.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Teachers and students at a participating school site, Adults and students/caregivers willing to participate in the study
  • 2. For Cue Centered Therapy:
  • 1. Youth aged 11-17 with exposure to at least one Diagnostic Statistical Manual (DSM) 5-defined traumatic event and meeting threshold criteria for posttraumatic symptoms per the University of California Los Angeles (UCLA) PTSD scale.
  • 2. Willingness to participate in therapy
  • 3. Caregiver willing to participate in therapy
  • 4. Perpetrator of the traumatic event is not living in the home with the child
  • Exclusion Criteria:
  • 1. For the general study and for Cue Centered Therapy:
  • 1. Students doing current trauma-focused interventions with a mental health professional
  • 2. Low cognitive functioning (IQ less than 70)
  • 3. Substance dependence as defined by DSM criteria
  • 4. Autism/Schizophrenia
  • 5. Clinically significant medical illness

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Palo Alto, California, United States

San Juan, , Puerto Rico

San Juan, , Puerto Rico

San Juan, , Puerto Rico

Patients applied

0 patients applied

Trial Officials

Victor Carrion, M.D.

Principal Investigator

John A. Turner, M.D. Professor and Vice-Chair of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Early Life Stress and Resilience Program

Alexander Urban, Ph.D.

Principal Investigator

Associate Professor

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials